Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. 1987

M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
Division of General Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

The effect of acetaminophen on reducing the frequency and severity of adverse reactions following diphtheria-pertussis-tetanus toxoids-polio vaccine was studied in a randomized clinical trial involving 519 vaccinations in 383 infants 2 to 6 months of age and 70 infants 18 months of age. Significantly fewer local and systemic reactions were reported in acetaminophen-treated infants at 2 to 6 months of age. Acetaminophen also reduced the incidence of fever greater than 38.0 degrees C from 44% to 27%. Only 0.9% of acetaminophen-treated infants had overall behavioral changes rated as severe by parents compared to 13% of the placebo group. Infants vaccinated at 18 months of age had higher rates of systemic and local reactions than younger infants. Acetaminophen did not result in significant reductions in reaction rates after the booster at 18 months. We conclude that acetaminophen administered at the time of primary vaccination with diphtheria-pertussis-tetanus toxoids-polio can significantly reduce the frequency and severity of common adverse reactions.

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D007223 Infant A child between 1 and 23 months of age. Infants
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010567 Pertussis Vaccine A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) Vaccine, Pertussis
D011054 Poliovirus Vaccine, Inactivated A suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent POLIOMYELITIS. Salk Vaccine,Inactivated Poliovirus Vaccine,Vaccine, Inactivated Poliovirus,Vaccine, Salk
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004168 Diphtheria Toxoid The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use). Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment. Diphtheria Vaccine,Toxoid, Diphtheria,Vaccine, Diphtheria
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
April 1988, The Pediatric infectious disease journal,
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
March 1993, American journal of diseases of children (1960),
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
October 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
January 1985, Pediatric infectious disease,
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
August 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
March 2006, Pediatrics,
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
April 1991, American journal of diseases of children (1960),
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
March 1990, Pediatrics,
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
October 2016, Indian pediatrics,
M M Ipp, and R Gold, and S Greenberg, and M Goldbach, and B B Kupfert, and D D Lloyd, and D C Maresky, and N Saunders, and S A Wise
January 1973, Medycyna doswiadczalna i mikrobiologia,
Copied contents to your clipboard!